The search for proteome-level markers of non-small cell lung cancer (NSCLC) has been mainly limited to serum or cell line screening approaches up to this point. We would like to demonstrate by this proof-of-principle study investigating bronchoalveolar lavage fluid samples from a cohort of NSCLC and control patients, that this readily available biofluid might be a more suitable source for discovering clinically usable NSCLC biomarkers.
Пожалуйста, войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)
Цитировать эту публикацию
%0 Journal Article
%1 oumeraci2011bronchoalveolar
%A Oumeraci, Tonio
%A Schmidt, Bernd
%A Wolf, Thomas
%A Zapatka, Marc
%A Pich, Andreas
%A Brors, Benedikt
%A Eils, Roland
%A Fleischhacker, Michael
%A Schlegelberger, Brigitte
%A von Neuhoff, Nils
%D 2011
%J Lung Cancer
%K Biological, Bronchoalveolar Carcinoma, Fluid; Humans; Lavage Lung Lung, Markers, Mass Neoplasms, Non-Small-Cell Proteomics; Spectrometry; Tumor diagnosis; metabolism
%N 1
%P 136--138
%R 10.1016/j.lungcan.2011.01.015
%T Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.
%U http://dx.doi.org/10.1016/j.lungcan.2011.01.015
%V 72
%X The search for proteome-level markers of non-small cell lung cancer (NSCLC) has been mainly limited to serum or cell line screening approaches up to this point. We would like to demonstrate by this proof-of-principle study investigating bronchoalveolar lavage fluid samples from a cohort of NSCLC and control patients, that this readily available biofluid might be a more suitable source for discovering clinically usable NSCLC biomarkers.
@article{oumeraci2011bronchoalveolar,
__markedentry = {[bbrors:6]},
abstract = {The search for proteome-level markers of non-small cell lung cancer (NSCLC) has been mainly limited to serum or cell line screening approaches up to this point. We would like to demonstrate by this proof-of-principle study investigating bronchoalveolar lavage fluid samples from a cohort of NSCLC and control patients, that this readily available biofluid might be a more suitable source for discovering clinically usable NSCLC biomarkers.},
added-at = {2015-04-09T12:36:21.000+0200},
author = {Oumeraci, Tonio and Schmidt, Bernd and Wolf, Thomas and Zapatka, Marc and Pich, Andreas and Brors, Benedikt and Eils, Roland and Fleischhacker, Michael and Schlegelberger, Brigitte and {von Neuhoff}, Nils},
biburl = {https://www.bibsonomy.org/bibtex/2030cd71e39abcd92f9db315fe4e131c0/bbrors},
doi = {10.1016/j.lungcan.2011.01.015},
interhash = {df0301758dc66caab96d81174da50f42},
intrahash = {030cd71e39abcd92f9db315fe4e131c0},
journal = {Lung Cancer},
keywords = {Biological, Bronchoalveolar Carcinoma, Fluid; Humans; Lavage Lung Lung, Markers, Mass Neoplasms, Non-Small-Cell Proteomics; Spectrometry; Tumor diagnosis; metabolism},
language = {eng},
medline-pst = {ppublish},
month = Apr,
number = 1,
owner = {bbrors},
pages = {136--138},
pii = {S0169-5002(11)00051-1},
pmid = {21334092},
timestamp = {2015-04-09T12:36:21.000+0200},
title = {Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.},
url = {http://dx.doi.org/10.1016/j.lungcan.2011.01.015},
volume = 72,
year = 2011
}